IKT Hisse Senedi Fiyat Grafiği
IKT Kazanmak
Inhibikase Therapeutics Inc
$1.68
0.73%
$0.01
Bugün itibarıyla:Jun 12, 15:05:22 GMT-4
Geri
Inhibikase Therapeutics Inc (IKT) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$1.67
Açılış fiyatı
$1.68
Günün Aralığı
$1.66 - $1.71
52 haftalık aralık
$1.33 - $2.26
İşlem hacmi
311.6K
Ort.Hacim
1.5M
Dividend yield
--
EPS (TTM)
-1.15
Piyasa Değeri
$222.1M
IKT nedir?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 35 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
